DHI
37
-3
AON
63
-2
CAH
61
-5
AAPL
53
-2
APD
52
-3
CPB
37
-2
EMR
60
-7
CMI
69
-2
DTE
40
-5
COST
48
-3
AMP
61
-3
CB
62
-5
AVB
35
-7
CMA
59
-2
CNX
40
-2
CVS
41
-2
AMG
75
-4
AMGN
31
-3
EQIX
65
-2
DE
42
-3
DHI
37
-3
AON
63
-2
CAH
61
-5
AAPL
53
-2
APD
52
-3
CPB
37
-2
EMR
60
-7
CMI
69
-2
DTE
40
-5
COST
48
-3
AMP
61
-3
CB
62
-5
AVB
35
-7
CMA
59
-2
CNX
40
-2
CVS
41
-2
AMG
75
-4
AMGN
31
-3
EQIX
65
-2
DE
42
-3
Financhill
Back

LeaderShares AlphaFactor Tactical Focused ETF Vs. Corcept Therapeutics, Inc. Industry Stock Comparison

Buy
60

LSAT
LeaderShares AlphaFactor Tactical Focused ETF

Last Price:
$39.20
Seasonality Move:
3.88%
Sell
30

CORT
Corcept Therapeutics, Inc.

Last Price:
$34.79
Seasonality Move:
13.21%
Buy
60
LeaderShares AlphaFactor Tactical Focused ETF (LSAT) is a Buy

Is LeaderShares AlphaFactor Tactical Focused ETF a Buy, Sell or Hold?

  • The current LeaderShares AlphaFactor Tactical Focused ETF [LSAT] share price is $38.86. The Score for LSAT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • LSAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Corcept Therapeutics, Inc. (CORT) is a Sell

Is Corcept Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Corcept Therapeutics, Inc. [CORT] share price is $34.80. The Score for CORT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CORT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LSAT Stock Price Chart

What is LeaderShares AlphaFactor Tactical Focused ETF's stock price today?

  • The LeaderShares AlphaFactor Tactical Focused ETF share price today is $38.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LSAT is experiencing selling pressure, which indicates risk of future bearish movement.

CORT Stock Price Chart

What is Corcept Therapeutics, Inc.'s stock price today?

  • The Corcept Therapeutics, Inc. share price today is $34.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing slight selling pressure.

LSAT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 32.79 Sell
Chaikin Money Flow: -4561 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.36 - 40.32) Sell
Bollinger Bands (100): (39.74 - 41.46) Sell

CORT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.88 Sell
Relative Strength Index (14 RSI): 14.83 Sell
Chaikin Money Flow: -8077532 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.63 - 90.59) Sell
Bollinger Bands (100): (69.66 - 84.14) Sell

LSAT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.3 Sell
20-day SMA: 39.8 Sell
50-day SMA: 39.96 Sell
200-day SMA: 39.99 Sell
8-day EMA: 39.32 Sell
20-day EMA: 39.63 Sell
50-day EMA: 39.41 Sell
200-day EMA: 26.54 Buy

CORT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.24 Sell
20-day SMA: 80.76 Sell
50-day SMA: 77.62 Sell
200-day SMA: 73.92 Sell
8-day EMA: 69.79 Sell
20-day EMA: 76.79 Sell
50-day EMA: 77.19 Sell
200-day EMA: 51.2 Sell

LeaderShares AlphaFactor Tactical Focused ETF Earnings Growth & LSAT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Corcept Therapeutics, Inc. Earnings Growth & CORT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $3.04 per share.

LeaderShares AlphaFactor Tactical Focused ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corcept Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):